![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.indianpharmapost.com/news/dabur-q1-fy25-consolidated-net-profit-up-8-at-rs-500-cr-15963
https://www.indianpharmapost.com/news/dabur-india-updates-on-q1-fy25-15847
https://www.reuters.com/business/retail-consumer/indias-religare-asked-seek-regulatory-nod-top-investor-raising-stake-2024-06-20/
https://www.indianpharmapost.com/news/dabur-india-posts-q4-fy24-consolidated-pat-at-rs-34953-cr-15599
https://www.reuters.com/legal/dabur-india-says-two-its-three-units-dismissed-cancer-lawsuit-us-2023-11-15/
https://www.reuters.com/business/healthcare-pharmaceuticals/dabur-indias-units-face-lawsuits-us-canada-alleging-products-caused-cancer-2023-10-18/
https://www.indianpharmapost.com/news/dabur-india-consolidated-q3fy23-pat-lower-at-rs-47594-cr-13682